USD 224.0
(0.0%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | 205.2 Million EUR | -50.08% |
2022 | 678.1 Million EUR | 112.64% |
2021 | 318.9 Million EUR | 51.79% |
2020 | 210.09 Million EUR | 34.08% |
2019 | 156.69 Million EUR | 10.86% |
2018 | 141.34 Million EUR | 23.2% |
2017 | 114.73 Million EUR | 11.46% |
2016 | 102.93 Million EUR | -18.5% |
2015 | 126.3 Million EUR | 160.45% |
2014 | 48.49 Million EUR | -7.5% |
2013 | 52.42 Million EUR | 8.07% |
2012 | 48.51 Million EUR | 16.71% |
2011 | 41.56 Million EUR | 33.99% |
2010 | 31.02 Million EUR | 3081.54% |
2009 | 975 Thousand EUR | -92.11% |
2008 | 12.36 Million EUR | -58.98% |
2007 | 30.13 Million EUR | 3.84% |
2006 | 29.01 Million EUR | 31.24% |
2005 | 22.11 Million EUR | 45.15% |
2004 | 15.23 Million EUR | 249.08% |
2003 | 4.36 Million EUR | 9.4% |
2002 | 3.98 Million EUR | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q2 | 23.9 Million EUR | -34.88% |
2024 Q3 | 8.3 Million EUR | -65.27% |
2024 Q1 | 36.7 Million EUR | -46.73% |
2023 Q4 | 68.9 Million EUR | 701.16% |
2023 FY | 338.5 Million EUR | -50.08% |
2023 Q2 | 95 Million EUR | 2.04% |
2023 Q1 | 93.1 Million EUR | -38.91% |
2023 Q3 | 8.6 Million EUR | -90.95% |
2022 Q4 | 152.4 Million EUR | 0.66% |
2022 FY | 678.1 Million EUR | 112.64% |
2022 Q1 | 205.7 Million EUR | 775.77% |
2022 Q2 | 165.8 Million EUR | -19.4% |
2022 Q3 | 151.4 Million EUR | -8.69% |
2021 Q1 | 90.3 Million EUR | 17.01% |
2021 FY | 318.9 Million EUR | 51.79% |
2021 Q2 | 111.1 Million EUR | 23.03% |
2021 Q3 | 106.4 Million EUR | -4.23% |
2021 Q4 | 23.48 Million EUR | -77.92% |
2020 Q2 | 33.9 Million EUR | -26.14% |
2020 Q4 | 77.17 Million EUR | 16.58% |
2020 Q1 | 45.9 Million EUR | 29.49% |
2020 FY | 210.09 Million EUR | 34.08% |
2020 Q3 | 66.2 Million EUR | 95.28% |
2019 Q1 | 37.8 Million EUR | -24.31% |
2019 Q3 | 39 Million EUR | -12.36% |
2019 Q4 | 35.44 Million EUR | -9.11% |
2019 FY | 156.69 Million EUR | 10.86% |
2019 Q2 | 44.5 Million EUR | 17.72% |
2018 Q4 | 49.94 Million EUR | 46.46% |
2018 Q1 | 26.6 Million EUR | -33.72% |
2018 FY | 141.34 Million EUR | 23.2% |
2018 Q3 | 34.1 Million EUR | 11.07% |
2018 Q2 | 30.7 Million EUR | 15.41% |
2017 Q3 | 22.3 Million EUR | 95.61% |
2017 FY | 114.73 Million EUR | 11.46% |
2017 Q2 | 11.4 Million EUR | -57.14% |
2017 Q4 | 40.13 Million EUR | 79.96% |
2017 Q1 | 26.6 Million EUR | 17.53% |
2016 Q2 | 29.1 Million EUR | 19.75% |
2016 Q4 | 22.63 Million EUR | -15.87% |
2016 Q1 | 24.3 Million EUR | 22.71% |
2016 Q3 | 26.9 Million EUR | -7.56% |
2016 FY | 102.93 Million EUR | -18.5% |
2015 Q4 | 19.8 Million EUR | -31.95% |
2015 Q1 | 49.8 Million EUR | 332.14% |
2015 Q2 | 27.1 Million EUR | -45.58% |
2015 Q3 | 29.1 Million EUR | 7.38% |
2015 FY | 126.3 Million EUR | 160.45% |
2014 Q3 | 15 Million EUR | 28.21% |
2014 FY | 48.49 Million EUR | -7.5% |
2014 Q4 | 11.52 Million EUR | -23.17% |
2014 Q2 | 11.7 Million EUR | 6.36% |
2014 Q1 | 11 Million EUR | -15.54% |
2013 Q2 | 14.3 Million EUR | 276.32% |
2013 Q4 | 13.02 Million EUR | 5.89% |
2013 FY | 52.42 Million EUR | 8.07% |
2013 Q1 | 3.8 Million EUR | -66.4% |
2013 Q3 | 12.3 Million EUR | -13.99% |
2012 Q3 | 14.8 Million EUR | 8.03% |
2012 Q1 | 15.7 Million EUR | 57.58% |
2012 Q2 | 13.7 Million EUR | -12.74% |
2012 FY | 48.51 Million EUR | 16.71% |
2012 Q4 | 11.31 Million EUR | -23.58% |
2011 Q2 | 8.6 Million EUR | -14.0% |
2011 Q1 | 10 Million EUR | -82.76% |
2011 Q3 | 12.9 Million EUR | 50.0% |
2011 Q4 | 9.96 Million EUR | -22.77% |
2011 FY | 41.56 Million EUR | 33.99% |
2010 Q1 | 7.1 Million EUR | 300.0% |
2010 Q4 | 58.02 Million EUR | 607.56% |
2010 FY | 31.02 Million EUR | 3081.54% |
2010 Q2 | 6.9 Million EUR | -2.82% |
2010 Q3 | 8.2 Million EUR | 18.84% |
2009 Q2 | -7.1 Million EUR | -408.7% |
2009 Q1 | 2.3 Million EUR | 0.0% |
2009 Q4 | 1.77 Million EUR | -63.78% |
2009 Q3 | 4.9 Million EUR | 169.01% |
2009 FY | 975 Thousand EUR | -92.11% |
2008 FY | 12.36 Million EUR | -58.98% |
2007 FY | 30.13 Million EUR | 3.84% |
2006 FY | 29.01 Million EUR | 31.24% |
2005 FY | 22.11 Million EUR | 45.15% |
2004 FY | 15.23 Million EUR | 249.08% |
2003 FY | 4.36 Million EUR | 9.4% |
2002 FY | 3.98 Million EUR | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
American Medical Technologies Inc. | -926.89 Thousand USD | 22238.478% |
Ansell Limited | 76.5 Million USD | -168.235% |
Ansell Limited | 76.5 Million USD | -168.235% |
BG Medicine, Inc. | - USD | -Infinity% |
Biotage AB (publ) | 24.28 Million USD | -745.133% |
BioLife Sciences Inc. | - USD | -Infinity% |
CB Scientific, Inc. | -1.63 Million USD | 12687.081% |
Psykey, Inc. | -1.32 Million USD | 15599.063% |
ConvaTec Group Plc | 130.3 Million USD | -57.483% |
ConvaTec Group Plc | 130.3 Million USD | -57.483% |
Encision Inc. | -691.78 Thousand USD | 29762.481% |
Golden Valley Development, Inc | -141.81 Thousand USD | 144799.635% |
Hear AtLast Holdings, Inc. | -234.36 Thousand USD | 87655.362% |
Innovative MedTech Inc. | -7.93 Million USD | 2684.742% |
LifePoint, Inc. | -15.23 Million USD | 1447.2% |
Medite Cancer Diagnostics, Inc. | -6.81 Million USD | 3112.773% |
Paradigm Medical Industries, Inc. | -474 Thousand USD | 43391.139% |
QuantRx Biomedical Corporation | - USD | -Infinity% |
Remedent, Inc. | -274.44 Thousand USD | 74868.807% |
Reflect Scientific, Inc. | -459.02 Thousand USD | 44803.155% |
SmileDirectClub, Inc. | -86.4 Million USD | 337.489% |
Sector 10, Inc. | 7036.00 USD | -2916329.79% |
Shandong Weigao Group Medical Polymer Company Limited | 2 Billion USD | 89.75% |
SheerVision, Inc. | -71.37 Thousand USD | 287591.594% |
United Health Products, Inc. | -2.62 Million USD | 7922.307% |
Vasamed, Inc. | -4.88 Million USD | 4297.905% |
Wearable Health Solutions, Inc. | -2.38 Million USD | 8691.285% |
Yubo International Biotech Limited | -1.2 Million USD | 17132.367% |